Literature DB >> 6136881

The characteristics of adrenoceptors in homogenates of human cerebral cortex labelled by (3H)-rauwolscine.

R J Summers, D B Barnett, S R Nahorski.   

Abstract

The alpha-2-adrenoceptor antagonist (3H)-rauwolscine has been used to label adrenoceptors in membranes from human cerebral cortex. The radioligand binds with high affinity (KD 2.08 nM) to a single population of sites with a density of 135 fmoles/mg protein. Adrenoceptor antagonists displaced binding in a simple monomolecular fashion with an order of affinity rauwolscine greater than yohimbine greater than phentolamine greater than corynanthine greater than prazosin indicating binding to alpha-2-adrenoceptors. Agonists displaced with an order of affinity clonidine greater than (-) adrenaline greater than (-) noradrenaline greater than dopamine greater than (-) isoprenaline but all displayed apparent Hill coefficients less than unity indicating heterogeneity of binding. The relatively high affinity of the alpha-1 antagonist prazosin for (3H)-rauwolscine binding sites in rat cerebral cortex was not observed in the human tissue which had pharmacological properties similar to those described previously in human platelet.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136881     DOI: 10.1016/0024-3205(83)90667-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

3.  Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes.

Authors:  G Maura; G Bonanno; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

4.  Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743.

Authors:  D J Pettibone; B V Clineschmidt; V J Lotti; J J Baldwin; J R Huff; W C Randall; J Vacca; S D Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

5.  Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.